The Application Value of Spectral CT in the Accurate Staging of Breast Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorYunnan Cancer Hospital

About this trial

Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Eligibility criteria

Qualifiers

(a) Chest quark energy spectrum CT examination was performed within 1 week before treatment

(b) Age ≥ 18

(c) Suspected breast cancer patients

(d) Patients who signed informed consent

Disqualifiers

(a) Severe cardiac, pulmonary and renal insufficiency

(b) Allergic to iodine contrast media

(c) Unable to cooperate to complete CT examination

(d) Quark spectrum CT image is poor and cannot be used

Trial design

Treatments tested in this trial

  • To explore the value of spectral CT in the diagnosis and treatment of breast cancer

Treatment groups

150 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators